RudaCure proyecto number: VC230007
The proyecto is programado to run for two years starting November 1, 2023, with the goal of developing an osteoartritis tratamiento del dolor.
IP Darae Strategic Commercialization Center is designated as the operating agency for this proyecto and will be collaborating with RudaCure on the initiative.